Due to the major role as a key regulator during serotonergic neurotransmission, 5-HTT represents an important molecular target which is involved in the treatment of neuropsychiatric disorders (e.g. depression, anxiety and post-traumatic stress disorders (PTSD)) [13]–[22]. The gene discussed is SLC6A4; the disease is major depressive disorder.